Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 201.15

-1.3%

Jan 23 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (29983)	1/9/2000 1:20:00 PM
From: Andreas Helke	Read Replies (1) of 32384

A few weeks ago I did read a post from an oncologist (probably on yahoo or raging bull) that claimed it was unreasonable to expect Targretin approval for early CTCL because there exist several approved therapies for early CTCL that can delay the progression of the disease for several years. When I read the testimonials of CTCL patients that you posted those alternative therapies seemed not to work very well compared with Targretin an I am happy that the FDA ignored the vote of its review panel and approved Targretin for early CTCL too. Andreas

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next